{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:24:45Z","timestamp":1792877085649,"version":"4.5.0"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800822"],"award-info":[{"award-number":["81800822"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004377","name":"Hong Kong Polytechnic University","doi-asserted-by":"publisher","award":["ZVS7"],"award-info":[{"award-number":["ZVS7"]}],"id":[{"id":"10.13039\/501100004377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:p>Signs and symptoms of optic neuritis (ON), an autoimmune disorder of the central nervous system (CNS), differ between patients. Pain, which is commonly reported by ON patients, may be the major reason for some patients to visit the clinic. This article reviews the presence of pain related to ON with respect to underlying disorders, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein associated disease (MOGAD). The aim of this review is to provide an overview of pain symptoms in accordance with the context of various pathophysiological explanations, assist in differential diagnosis of ON patients, especially at the onset of disease, and make recommendations to aid physicians make decisions for follow up diagnostic examinations.<\/jats:p>","DOI":"10.3389\/fpain.2022.865032","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T05:53:35Z","timestamp":1649915615000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Pain Symptoms in Optic Neuritis"],"prefix":"10.3389","volume":"3","author":[{"given":"Xiayin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Ho-lung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"101965","DOI":"10.1016\/j.msard.2020.101965","article-title":"Prodromal headache in MOG-antibody positive optic neuritis","volume":"40","author":"Asseyer","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00417-007-0722-2","article-title":"Visual field defects in acute optic neuritis\u2014distribution of different types of defect pattern, assessed with threshold-related supraliminal perimetry, ensuring high spatial resolution","volume":"246","author":"Nevalainen","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jaut.2014.01.022","article-title":"The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review","author":"Karussis","year":"2014","journal-title":"J Autoimmun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/NRL.0b013e31823d7acd","article-title":"Early diagnosis, monitoring, and treatment of optic neuritis","volume":"18","author":"Chan","year":"2012","journal-title":"Neurologist"},{"key":"B5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0161-6420(94)31103-1","article-title":"The course of visual recovery after optic neuritis","volume":"101","author":"Beck","year":"1994","journal-title":"Exp Optic Neuritis Treat Trial Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s00415-016-8155-7","article-title":"Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages","volume":"263","author":"Zhou","year":"2016","journal-title":"J Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/WNO.0b013e3181f68c19","article-title":"Should most patients with optic neuritis be tested for neuromyelitis optica antibodies and should this affect their treatment?","volume":"30","author":"Galetta","year":"2010","journal-title":"J Neuroophthalmol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1468-1331.2010.03066.x","article-title":"EFNS guidelines on diagnosis and management of neuromyelitis optica","volume":"17","author":"Sellner","year":"2010","journal-title":"Eur J Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"B13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/WCO.0000000000000766","article-title":"Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis","volume":"33","author":"Chen","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/brain\/awg045","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION)","volume":"126","author":"Kidd","year":"2003","journal-title":"Brain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s004170050062","article-title":"Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features","volume":"236","author":"Gerling","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0002-9394(99)00304-9","article-title":"Comparison of central and peripheral visual field properties in the optic neuritis treatment trial","volume":"128","author":"Keltner","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1212\/WNL.0b013e3181ea9f15","article-title":"Familial neuromyelitis optica","volume":"75","author":"Matiello","year":"2010","journal-title":"Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/s0165-5728(00)00444-6","article-title":"Multiple sclerosis: genomic rewards","volume":"113","author":"Oksenberg","year":"2001","journal-title":"J Neuroimmunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/1352458509350741","article-title":"HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis","volume":"16","author":"Brum","year":"2010","journal-title":"Mult Scler"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s12264-013-1457-1","article-title":"No association between identified multiple sclerosis non-MHC risk loci and neuromyelitis optica","volume":"30","author":"Liu","year":"2014","journal-title":"Neurosci Bull"},{"key":"B21","doi-asserted-by":"publisher","first-page":"577045","DOI":"10.1016\/j.jneuroim.2019.577045","article-title":"The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population","volume":"337","author":"Liang","year":"2019","journal-title":"J Neuroimmunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10072-018-3334-1","article-title":"Pain in optic neuropathies","volume":"39","author":"Marzoli","year":"2018","journal-title":"Neurol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0161-6420(03)00477-9","article-title":"Optic neuritis: correlation of pain and magnetic resonance imaging","volume":"110","author":"Fazzone","year":"2003","journal-title":"Ophthalmology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"s75","DOI":"10.1007\/s10072-005-0413-y","article-title":"Controversies in optic neuritis pain diagnosis","volume":"2","author":"Agostoni","year":"2005","journal-title":"Neurol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1001\/archneur.1991.00530190096021","article-title":"The origin of pain in optic neuritis. Determinants of pain in 101 eyes with optic neuritis","volume":"48","author":"Lepore","year":"1991","journal-title":"Arch Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.4103\/0028-3886.294831","article-title":"Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder","volume":"68","author":"Ojha","year":"2020","journal-title":"Neurol India"},{"key":"B27","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult Scler"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2055217318791196","DOI":"10.1177\/2055217318791196","article-title":"Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis","volume":"4","author":"Srikajon","year":"2018","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"B29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology. Clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1152\/physrev.00025.2008","article-title":"Models and mechanisms of hyperalgesia and allodynia","volume":"89","author":"Sandk\u00fchler","year":"2009","journal-title":"Physiol Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"B32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40135-015-0073-9","article-title":"What Causes Eye Pain?","volume":"3","author":"Belmonte","year":"2015","journal-title":"Curr Ophthalmol Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1523\/JNEUROSCI.0381-04.2004","article-title":"A novel class of neurons at the trigeminal subnucleus interpolaris\/caudalis transition region monitors ocular surface fluid status and modulates tear production","volume":"24","author":"Hirata","year":"2004","journal-title":"J Neurosci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/medicines6030091","article-title":"Pathological mechanisms and therapeutic targets for trigeminal neuropathic pain","volume":"6","author":"Bista","year":"2019","journal-title":"Medicines (Basel)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00415-012-6579-2","article-title":"A mechanism-based classification of pain in multiple sclerosis","volume":"260","author":"Truini","year":"2013","journal-title":"J Neurol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1082-3174(97)70011-4","article-title":"The nervi nervorum","volume":"6","author":"Bove","year":"1997","journal-title":"Pain Forum"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3791\/56185","article-title":"Induction of paralysis and visual system injury in mice by t cells specific for neuromyelitis optica autoantigen aquaporin-4","volume":"56185","author":"Sagan","year":"2017","journal-title":"J Vis Exp"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2013.10.004","article-title":"Neuroinflammation: the role and consequences","volume":"79","author":"Lyman","year":"2014","journal-title":"Neurosci Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.imbio.2019.05.010","article-title":"Mast cells: A key component in the pathogenesis of Neuromyelitis Optica Spectrum Disorder?","volume":"224","author":"Medeiros","year":"2019","journal-title":"Immunobiology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fncel.2019.00142","article-title":"Role of glutamatergic excitotoxicity in neuromyelitis optica spectrum disorders","volume":"13","author":"Da Silva","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"Cd001430","DOI":"10.1002\/14651858.CD001430.pub4","article-title":"Corticosteroids for treating optic neuritis","volume":"2015","author":"Gal","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/1352458508100837","article-title":"Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder","volume":"15","author":"Bonnan","year":"2009","journal-title":"Mult Scler"},{"key":"B43","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1177\/0333102417703761","article-title":"Facial pain: Overlapping syndromes","volume":"37","author":"Evers","year":"2017","journal-title":"Cephalalgia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/s41467-020-16625-7","article-title":"Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica","volume":"11","author":"Agasing","year":"2020","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.pain.2013.03.026","article-title":"Inhibition of IL-6 signaling: a novel therapeutic approach to treating spinal cord injury pain","volume":"154","author":"Guptarak","year":"2013","journal-title":"Pain"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.3389\/fimmu.2018.02066","article-title":"Low-dose mycophenolate mofetil for treatment of neuromyelitis optica spectrum disorders: a prospective multicenter study in South China","volume":"9","author":"Huang","year":"2018","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"112505","DOI":"10.1016\/j.biopha.2021.112505","article-title":"Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence","volume":"146","author":"Scuteri","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"B48","doi-asserted-by":"publisher","first-page":"102685","DOI":"10.1016\/j.msard.2020.102685","article-title":"Frequency of comorbidities in Neuromyelitis Optica spectrum disorder","volume":"48","author":"Barzegar","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1212\/NXI.0000000000000286","article-title":"Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder","volume":"3","author":"Chavarro","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1600-0447.2009.01529.x","article-title":"An update on the role of glutamate in the pathophysiology of depression","volume":"122","author":"Mitchell","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"B51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuropharm.2016.10.019","article-title":"Novel, highly potent and in vivo active inhibitor of GABA transporter subtype 1 with anticonvulsant, anxiolytic, antidepressant and antinociceptive properties","volume":"113","author":"Sa\u0142at","year":"2017","journal-title":"Neuropharmacology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/archneur.65.6.727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","year":"2008","journal-title":"Arch Neurol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jocn.2017.10.030","article-title":"Paraneoplastic neuromyelitis optica spectrum disorder: A case report and review of the literature","volume":"48","author":"Annus","year":"2018","journal-title":"J Clin Neurosci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"S174","DOI":"10.1016\/s0161-6420(94)31103-1","article-title":"The course of visual recovery after optic neuritis: experience of the optic neuritis treatment trial","volume":"127","author":"Beck","year":"2020","journal-title":"Ophthalmology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/1352458511421185","article-title":"Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy","volume":"18","author":"Barnett","year":"2012","journal-title":"Mult Scler"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1177\/1352458517734070","article-title":"A population-based prospective study of optic neuritis","volume":"23","author":"Soelberg","year":"2017","journal-title":"Mult Scler"},{"key":"B59","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3988\/jcn.2018.14.2.246","article-title":"Paraneoplastic Neuromyelitis Optica Associated with Lung Adenocarcinoma in a Young Woman","volume":"14","author":"Baik","year":"2018","journal-title":"J Clin Neurol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J Neuroinflammation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jns.2015.05.034","article-title":"Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review","volume":"355","author":"Pereira","year":"2015","journal-title":"J Neurol Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review","volume":"27","author":"Shahmohammadi","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B64","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jamaophthalmol.2017.6757","article-title":"Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial","volume":"136","author":"Chen","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ophtha.2018.03.041","article-title":"Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis","volume":"125","author":"Jitprapaikulsan","year":"2018","journal-title":"Ophthalmology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B68","volume-title":"A Retrospective Study of Chronic Relapsing Inflammatory Optic Neuropathy (CRION)(P6. 293)","author":"Sudhakar","year":"2014"},{"key":"B69","doi-asserted-by":"publisher","first-page":"117282","DOI":"10.1016\/j.jns.2020.117282","article-title":"A multi-center case series of sarcoid optic neuropathy","volume":"420","author":"Webb","year":"2021","journal-title":"J Neurol Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/08820530390895172","article-title":"Optic neuritis in adults and children","volume":"18","author":"Boomer","year":"2003","journal-title":"Semin Ophthalmol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jpeds.2003.10.056","article-title":"First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability","volume":"144","author":"Mikaeloff","year":"2004","journal-title":"J Pediatr"},{"key":"B72","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-2007-1019130","article-title":"Acute disseminated encephalomyelitis: current understanding and controversies","volume":"28","author":"Young","year":"2008","journal-title":"Semin Neurol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ejpn.2008.09.003","article-title":"Childhood optic neuritis: the pediatric neurologist's perspective","volume":"13","author":"Cakmakli","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/acn3.51147","article-title":"Genetic factors for susceptibility to and manifestations of neuromyelitis optica","volume":"7","author":"Matsushita","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s11910-012-0320-5","article-title":"Pain and multiple sclerosis: pathophysiology and treatment","volume":"13","author":"Solaro","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1177\/1352458515613643","article-title":"Prevalence of neuropathic pain in early multiple sclerosis","volume":"22","author":"Heitmann","year":"2016","journal-title":"Mult Scler"},{"key":"B77","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s13311-018-0633-4","article-title":"Neuropathic Pain After Spinal Cord Injury: Challenges and Research Perspectives","volume":"15","author":"Shiao","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1177\/1352458514522103","article-title":"Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life","volume":"20","author":"Zhao","year":"2014","journal-title":"Mult Scler"},{"key":"B79","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3238\/arztebl.2015.0616","article-title":"The diagnosis and treatment of optic neuritis","volume":"112","author":"Wilhelm","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00415-014-7349-0","article-title":"The incidence of clinically isolated syndrome in a multi-ethnic cohort","volume":"261","author":"Langer-Gould","year":"2014","journal-title":"J Neurol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ophtha.2019.04.042","article-title":"Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan","volume":"126","author":"Ishikawa","year":"2019","journal-title":"Ophthalmology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3341\/kjo.2012.26.2.111","article-title":"Clinical characteristics of optic neuritis in Koreans greater than 50 years of age","volume":"26","author":"Choi","year":"2012","journal-title":"Korean J Ophthalmol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/j.1468-2982.2004.00790.x","article-title":"Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia","volume":"24","author":"D'Amico","year":"2004"},{"key":"B84","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1526-4610.2005.05136.x","article-title":"The association of brainstem lesions with migraine\u0393\u00c7\u00c9like headache: an imaging study of multiple sclerosis","volume":"45","author":"Gee","year":"","journal-title":"Headache"},{"key":"B85","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jns.2006.01.015","article-title":"Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis","volume":"244","author":"Tortorella","year":"2006"},{"key":"B86","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s10072-008-0908-3","article-title":"Primary headache and multiple sclerosis: preliminary results of a prospective study","volume":"29","author":"Villani","year":"2008"},{"key":"B87","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.nrleng.2014.12.015","article-title":"Neuromyelitis optica: association with paroxysmal painful tonic spasms","volume":"31","author":"Carnero Contentti","year":"2016","journal-title":"Neurologia"},{"key":"B88","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1212\/WNL.0b013e318229e694","article-title":"Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study","volume":"77","author":"Kanamori","year":"2011"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1001\/archneurol.2012.768","article-title":"Association of neuromyelitis optica with severe and intractable pain","volume":"69","author":"Qian","year":"2012","journal-title":"Arch Neurol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1177\/1352458513507822","article-title":"Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients","volume":"20","author":"Kremer","year":"2014","journal-title":"Mult Scler"},{"key":"B91","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3344\/kjp.2014.27.1.77","article-title":"A case of neuromyelitis optica misdiagnosed as cervicogenic headache","volume":"27","author":"Choi","year":"2014","journal-title":"Korean J Pain"},{"key":"B92","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.math.2015.09.008","article-title":"Physical examination tests for screening and diagnosis of cervicogenic headache: A systematic review","volume":"21","author":"Rubio-Ochoa","year":"2016","journal-title":"Man Ther"},{"key":"B93","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.msard.2016.01.006","article-title":"Trigeminal autonomic cephalalgia as a presenting feature of Neuromyelitis Optica: \u201cA rare combination of two uncommon disorders\u201d","volume":"6","author":"Mathew","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"B94","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1526-4610.2008.01121.x","article-title":"The international classification of headache disorders","volume":"48","author":"Olesen","year":"2008","journal-title":"Headache"},{"key":"B95","doi-asserted-by":"publisher","first-page":"569","DOI":"10.5692\/clinicalneurol.cn-000753","article-title":"A case of neuromyelitis optica presenting marked pleocytosis and hypoglycorrhachia","volume":"56","author":"Fujikura","year":"2016","journal-title":"Rinsho Shinkeigaku"},{"key":"B96","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev-neuro-060909-153234","article-title":"Sodium channels in normal and pathological pain","volume":"33","author":"Dib-Hajj","year":"2010","journal-title":"Annu Rev Neurosci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jns.2016.11.016","article-title":"Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring","volume":"372","author":"Evangelopoulos","year":"2017","journal-title":"A six-year follow-up J Neurol Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/ana.25648","article-title":"Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases","volume":"87","author":"Durozard","year":"2020","journal-title":"Ann Neurol"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2022.865032\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T05:53:42Z","timestamp":1649915622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2022.865032\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":98,"alternative-id":["10.3389\/fpain.2022.865032"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2022.865032","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,14]]},"article-number":"865032"}}